Cognitive effects of standard-dose chemotherapy in patients with cancer

Cancer Investigation

Volumn 19, Issue 8, 2001, Pages 812-820

  Ahles, Tim A ^a   Saykin, Andrew ^a  

^a DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

Author keywords

Chemotherapy induced cognitive deficits; Neuropsychological assessment

Indexed keywords

ANTINEOPLASTIC AGENT; CYTOTOXIC AGENT; ESTROGEN; TAMOXIFEN;

ARTICLE; CANCER CHEMOTHERAPY; CAREER; CLINICAL TRIAL; COGNITIVE DEFECT; EDUCATION; HEREDITY; HUMAN; INTELLIGENCE; LONGITUDINAL STUDY; MENOPAUSE; METHODOLOGY; NEUROPSYCHOLOGICAL TEST; NEUROTOXICITY; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; PSYCHOLOGICAL ASPECT; QUALITY OF LIFE; REHABILITATION;

ANTINEOPLASTIC AGENTS; BRAIN; COGNITION DISORDERS; FEMALE; HUMANS; MENOPAUSE; NEOPLASMS;

EID: 0035217019     PISSN: 07357907     EISSN: None     Source Type: Journal    
DOI: 10.1081/CNV-100107743     Document Type: Article

References (46)

1. Quality of life among long-term cancer survivors
2. Cognitive sequelae of treatment in children
3. Neuropsychological impact of cancer and cancer treatments in adults
4. Neurocognitive dysfunction in cancer patients
5. Development of an intervention to restore attention in cancer patients
6. "Chemo Brain:" cognitive impact of systemic chemotherapy
7. Psychosocial aspects of neoplastic disease: II. Affective and cognitive effects of chemotherapy in cancer patients
8. Serial cognitive testing in cancer patients receiving chemotherapy
9. Neuropsychological evaluation of patients with inoperable non-small cell lung cancer treated with combination chemotherapy or radiotherapy
10. Evaluation of cognitive function in patients with limited small cell lung cancer prior to and shortly following prophylactic cranial irradiation
11. Neuropsychological assessment of cognitive functioning following chemotherapy for breast cancer
12. Impairment of cognitive function in women receiving adjuvant treatment for high risk breast cancer: High dose versus standard dose chemotherapy
13. Cognitive deficits after postoperative adjuvant chemotherapy for breast carcinoma
14. Cognitive impact of standard-dose systemic chemotherapy in long-term survivors of breast cancer and lymphoma
15. Neurotoxicity secondary to antineoplastic drugs
16. Cisplatin-based therapy: A neurological and neuropsychological review
17. Quality of life of long-term adult survivors of autologous bone marrow transplantation
18. Psychologic and neuropsychologic functioning of patients with limited small-cell lung cancer treated with chemotherapy and radiation therapy with or without warfarin: A study by the cancer and leukemia group B
19. Neuropsychological outcome in survivors of pediatric bone marrow transplantation
20. Prospective longitudinal neuropsychological testing of patients receiving high dose chemotherapy: Results and methodological issues
21. Metabolic disorders and neuropsychiatric symptoms
22. Premorbid brain size as a determinant of reserve capacity against intellectual decline in Alzheimer's disease
23. Influence of cognitive reserve on neuropsychological functioning in asymptomatic human immunodeficiency virus-1 infection
24. Attentional fatigue following breast cancer surgery
25. What do cancer patients mean when they complain of concentration and memory problems?
26. Association of apolipoprotein E allele ε4 with late-on-set familial and sporadic Alzheimer's disease
27. Apolipoprotein E, a gene with complex biological interactions in the aging brain
28. Synergistic effects of traumatic head injury and apolipoprotein-ε4 in patients with Alzheimer's disease
29. Predictors of cognitive decline after cardiac operation
30. Preliminary report of a genetic basis for cognitive decline after cardiac operations
31. Apolipoprotein E phenotype and cognitive decline in a prospective study of elderly community women
32. The role of APOE ε4 in modulating effects of other risk factors for cognitive decline in elderly persons
33. Cognitive assessment for postmenopausal women and general assessment of their mental health
34. Estrogen and cognitive functioning in women
35. Estrogen use and verbal memory in healthy postmenopausal women
36. Estrogen improves psychological function in asymptomatic postmenopausal women
37. Estrogen replacement therapy and cognitive function in older women
38. Estrogen and cognitive functioning in surgically menopausal women
39. The female brain hypoestrogenic continuum from the premenstrual syndrome to menopause
40. Testosterone and depression in aging men
41. Review of Meyers, C.A. neurocognitive dysfunction in cancer patients
42. Clinical status and optimal use of Amifostine